期刊文献+

HCV包膜糖蛋白E2基因的克隆、蛋白表达及纯化 被引量:1

Cloning of HCV E2 gene and expression and purification of HCV envelope glycoprotein E2
下载PDF
导出
摘要 目的:获得大量重组HCVE2蛋白,为研究E2蛋白的功能及制备其抗体奠定基础.方法:利用PCR方法从HCV基因组序列中扩增出831bp(384-661aa)的E2基因片段并按读框克隆到原核表达载体pET32a(+)上,得到重组质粒pET32a-HCVE2,转化大肠杆菌BL-21(DE3)菌株,IFFG诱导HCVE2蛋白表达,SDS-PAGE和Westernblot检测蛋白表达,Ni-NTA偶联的琼脂糖黏附柱纯化融合蛋白.结果:经IPTG诱导后,可见分子量约55000的融合蛋白表达;表达的蛋白主要以包涵体形式存在;经Ni-NTA偶联的琼脂糖黏附柱纯化的融合蛋白与抗His抗体及HCV阳性血清具有良好的反应原性.结论:HCVE2基因的克隆、表达及其融合蛋白的纯化为进一步开展HCVE2蛋白功能和HCV受体的研究奠定了基础. AIM: To obtain large amount of HCV E2 protein, and to understand the function of the protein and to prepare the antibody against this protein. METHODS: A 831bp of E2 gene fragment was amplified by PCR method from HCV genome and cloned into pET32a (+) vector, an E.coli expression vector, to construct a re-combinant plasmid pET32a-HCVE2.The plasmid was transformed into Ecoli BL-21 (DE3) to express E2 protein with IPTG induced. The protein E2 fused with HIS tag was purification by Ni-NTA resin column. The protein E2 fused with His tag was detected by SDS-PAGE electrophoresis and Western blot. RESULTS: A novel protein with molecular weight of Mr 55 000 was expressed upon induction with IPTG in E.coli. The expressed product showed good reactivity to anti-His tag antibody and the HCV positive serum. CONCLUSION: Cloning of HCV E2 gene and the expression and purification of envelope glycoprotein E2 lay a foundation of further study on HCV E2 protein and the receptors of hepatitis virus C.
出处 《世界华人消化杂志》 CAS 2004年第2期315-318,共4页 World Chinese Journal of Digestology
基金 国家自然科学基金资助课题 No.30070687~~
  • 相关文献

参考文献14

二级参考文献140

共引文献77

同被引文献14

  • 1李刚.郑州地区不同人群HCV感染及HCV基因型研究[J].中国误诊学杂志,2004,4(3):343-345. 被引量:10
  • 2Lauer GM,Walker BD.Hepatitis C virus infection[J].N Engl J Med,2001,345(1):41-52.
  • 3Penin F,DubuissonJ,Rey FA,et al.Structural Biology of Hepatitis C Virus[J].Hepatology,2004,39(1):5-19.
  • 4Kuhn RJ,Zhang W,Rossmann MG,et al.Structure of dengue virus:implications for flavivirus organization,maturation and fusion[J].Cell,2002,108(5):717-725.
  • 5Bartosch B,Dubuisson J,Cosset FL.Infectious hepatitis C pseudoviruses containing functional E1E2 envelope protein complexes[J].Exp Med,2003,197(5):633-642.
  • 6Drummer HE,Wilson KA,Poumbourios P.Determinants of CD81dimerization and interaction with hepatitis C virus glycoprotien E2 [J].Biochem biophys res Commun,2005,328(1):251-257.
  • 7VanCompernolle SE,Wiznycia AV,Rush JR,et al.Small molecule inhibition of hepatitis C virus E2 binding to CD81[J].Virology,2003,314(1):371-380.
  • 8Bartosch B,Vitelli A,Granier C,et al.Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor[J].J Biol Chem,2003,278(43):41624-41630.
  • 9Scarselli E,Ansuini H,Cerino R,et al.The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus[J].EMBO J,2002,21(19):5017 -5025.
  • 10Gardner JP,Durso RJ,Arrigale RR,et al.L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus[J].Natl Acad Sci U S A,2003,100(8):4498-4503.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部